Inmunova

Business Services · Argentina · 11-50 Employees

View Company Info for Free

Overview

Headquarters

3278 Dir. Laprida 42, Boulogne, Buenos A...

Phone Number

+54 1120331455

Revenue

$5.2 Million

Industry

Business Services Research & Development
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1

About Inmunova

Inmunova is a biotechnology company focused on the research and development of innovative medications for rare infectious diseases that currently lack treatment options. Leveraging their expertise in protein and antibody engineering, they create therapeutic solutions for various diseases. Founded in 2009 by scientists, Inmunova emphasizes innovation and scientific rigor, adhering to global quality standards in their R&D practices. Their specialization includes the design of vaccines, therapeutic antibodies, and immunogens, covering the entire development process from preclinical to clinical research.Explore more
Inmunova's Social MediaPopular SearchesInmunova SAInmunovaInmunova aSIC Code 87,873NAICS Code 54,541Show more

Inmunova Org Chart

PhoneEmail
Santiago Sanguineti, Chief Operating Officer at Inmunova
Argentina flag for contact location.

Chief Operating Officer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Inmunova your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Illustration of an envelope

Company Profile Activity

i

Among all Business Services companies

Low Activity

High Activity

Activity Insights

Inmunova is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

Inmunova is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Inmunova.

Inmunova Tech Stack

A closer look at the technologies used by Inmunova

Top Business Services Companies

Frequently Asked Questions Regarding Inmunova

What is Inmunova's official website?
Inmunova's official website is www.inmunova.com
What is Inmunova's Revenue?
Inmunova's revenue is $5.2 Million
What is Inmunova's SIC code?
Inmunova's SIC: 87,873
What is Inmunova's NAICS code?
Inmunova's NAICS: 54,541
How many employees does Inmunova have?
Inmunova has 11-50 employees
What industry does Inmunova belong to?
Inmunova is in the industry of: Business Services, Research & Development
What technology does Inmunova use?
Some of the popular technologies that Inmunova uses are: Microsoft 365, Sectigo, Microsoft Exchange Online
How do I contact Inmunova?
Inmunova contact info: Phone number: +54 1120331455 Website: www.inmunova.com
What does Inmunova do?

Inmunova is a biotechnology company focused on the research and development of innovative medications for rare infectious diseases that currently lack treatment options. Leveraging their expertise in protein and antibody engineering, they create therapeutic solutions for various diseases. Founded in 2009 by scientists, Inmunova emphasizes innovatio... n and scientific rigor, adhering to global quality standards in their R&D practices. Their specialization includes the design of vaccines, therapeutic antibodies, and immunogens, covering the entire development process from preclinical to clinical research.Read More

What are Inmunova social media links?
Inmunova Linkedin page Inmunova Twitter page Inmunova Facebook page
Is Inmunova a public company?
Inmunova is private company therefore does not currently have an official ticker symbol
See more information about Inmunova

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.